Cartesian Therapeutics, Inc.'s (NASDAQ:RNAC) market cap rose US$14m last week; retail investors who hold 50% profited and so did insiders

Key Insights The considerable ownership by retail investors in Cartesian Therapeutics indicates that they collectively...

Related Keywords

Timothy Springer ,Murat Kalayoglu ,Cartesian Therapeutics Inc , ,Cartesian Therapeutics ,Retail Investors ,Nstitutional Ownership ,Institutional Investors ,